KOSDAQ · Healthcare · ₩481B
₩48,750+4.61%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.6% · as of 26.10.27
Among 15 신약 개발 peers
Quarterly Revenue Growth
“사업 전환을 위한 투자가 먼저 진행되며 다음 성장을 준비한 분기였어요.”
In the company's words · 2026 2분기 filing